Elbasvir/grazoprevir treatment in an HCV-infected peritoneal dialysis patient

Hepatitis C virus (HCV) infection is known to affect long-term patient survivals. Elbasvir/grazoprevir (EBR/GZR) has shown a high cure rate in hemodialysis patients with HCV infection. However, the combination is rarely used in peritoneal dialysis patients. Herein, we report a case of successful tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jin, Li, Yi, Li, Guisen, Lei, Pu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178844/
https://www.ncbi.nlm.nih.gov/pubmed/32301365
http://dx.doi.org/10.1080/0886022X.2020.1753073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178844/
https://www.ncbi.nlm.nih.gov/pubmed/32301365
http://dx.doi.org/10.1080/0886022X.2020.1753073

Ejemplares similares